UPDATE 3-FDA declines to approve Cingulate's ADHD treatment over manufacturing issues

5

(Adds shares in paragraph 3, analyst comment in paragraphs 4 and 11, background in paragraphs 5, 6 and 8) By Siddhi Mahatole June 2 (Reuters) – Drug developer Cingulate said on Tuesday the U.S. Food

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)